Overview

ADAPT: Addressing Depression and Pain Together

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The primary question addressed by this study is: Using a stepped care approach in primary care, what is the value of the combination of an antidepressant medication (Venlafaxine) and psychotherapy for seniors living with depression and chronic lower back pain when treatment with a low-dose of venlafaxine and supportive management (SM) has led to only a partial or non-response?
Phase:
Phase 4
Details
Lead Sponsor:
University of Pittsburgh
Treatments:
Venlafaxine Hydrochloride